Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / autolus therapeutics to host analyst investor event mwn benzinga


AUTL - Autolus Therapeutics to Host Analyst / Investor event at the American Society of Hematology (ASH) Annual Meeting 2023 | Benzinga

    • In-person and webcast event on Sunday, 10 December, 2023 at 8:00 AM PT / 4:00 PM GMT

    • Review of pooled analysis of the ongoing FELIX Phase Ib/II study, pooled analysis from ALLCAR19 and FELIX Phase Ib studies and ALLCAR19 extension with obe-cel, as well as initial data from the AUTO8 MCARTY Phase I Study

    LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, will host an in-person Analyst/Investor event during the 65th ASH Annual Meeting in San Diego.

    Date: Sunday, December 10, 2023
    Time: The presentation will be from 8:00 AM PT / 4:00 PM GMT to 9:00 AM PT / 5:00 PM GMT. Onsite access to the event available from 7:45am PT
    Venue: The Manchester Grand Hyatt, 1 Market Place, San Diego, CA 92101
    Room: Cityview AB Room on the 32nd floor
    Speakers: Dr. Claire Roddie, MD, PhD, FRCPath, Associate Professor Haematology and Honorary Consultant Haematologist, Cancer Institute, University College London (UCL); Dr. Christian Itin, Chief Executive Officer, Autolus.
    Webcast Registration: A live webcast will be held alongside the event. To register for the webcast please follow this link.

    A recording of the event together with the presentation materials will be available on the Company's website after the event.

    Reminder: Timings and Details of Oral Presentations:

    1. Title: Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory Adult B-cell Acute Lymphoblastic Leukemia (R/R B-ALL): Pooled Analysis of the Ongoing FELIX Phase Ib/II Study
      Link to Poster
      Session Title: 704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Expanding Disease Targets for CAR-T Cell Therapies
      Session date and time: Saturday, December 9, 2023, 3:15 PM PT
      Session room: San Diego Convention Center, Room 6B
      Publication Number: 222
      Presenting Author: Dr. Claire Roddie, MD, PhD, FRCPath, Associate Professor Haematology and Honorary Consultant Haematologist, ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: Autolus Therapeutics plc
    Stock Symbol: AUTL
    Market: NASDAQ

    Menu

    AUTL AUTL Quote AUTL Short AUTL News AUTL Articles AUTL Message Board
    Get AUTL Alerts

    News, Short Squeeze, Breakout and More Instantly...